Recognition of drug margin will trigger unfair trade competition

Published: 2002-04-23 06:57:00

Updated: 2002-04-23 06:57:00

The domestic pharmaceutical industry has recently denounced the government's drug related policy to allow the drug margin up to 50 percent on the medical institutions which will purchase the lowest insurance-covered drugs in the same therapeutic category, in a bid to discourage the use of the hig...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK